Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea
· Delayed Price · Currency is KRW
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Oct '24 Oct 10, 2024 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 19,700 | 19,700 | 15,410 | 35,741 | 51,626 | 78,193 | |
| Market Cap Growth | -45.97% | 27.84% | -56.88% | -30.77% | -33.98% | -46.23% | |
| Enterprise Value | 51,099 | 38,909 | 36,636 | 69,920 | 79,902 | 92,488 | |
| Last Close Price | 2725.00 | 2725.00 | 2725.00 | 4950.00 | 7150.00 | 10150.00 | |
| PS Ratio | 0.54 | 0.54 | 0.30 | 0.57 | 0.84 | 1.62 | |
| PB Ratio | -0.86 | -0.86 | 1.88 | 1.18 | 1.06 | 1.46 | |
| P/TBV Ratio | - | - | 2.07 | 1.22 | 1.10 | 1.55 | |
| P/OCF Ratio | - | - | 36.67 | 26.24 | - | 40.84 | |
| EV/Sales Ratio | 1.40 | 1.07 | 0.71 | 1.11 | 1.30 | 1.92 | |
| EV/EBITDA Ratio | - | - | - | - | 15.18 | - | |
| EV/EBIT Ratio | - | - | - | - | 62.84 | - | |
| Debt / Equity Ratio | -0.94 | -0.94 | 2.92 | 1.30 | 0.76 | 0.67 | |
| Debt / EBITDA Ratio | - | - | - | - | 7.05 | - | |
| Net Debt / Equity Ratio | -0.65 | -0.65 | 2.22 | 1.06 | 0.61 | 0.28 | |
| Net Debt / EBITDA Ratio | -0.69 | -0.69 | -1.16 | -2.98 | 5.62 | -2.31 | |
| Net Debt / FCF Ratio | -12.08 | -12.08 | -34.45 | -35.70 | -3.51 | -2.81 | |
| Asset Turnover | 0.60 | 0.60 | 0.61 | 0.61 | 0.53 | 0.45 | |
| Inventory Turnover | 3.13 | 3.13 | 3.57 | 4.11 | 3.18 | 2.72 | |
| Quick Ratio | 0.24 | 0.24 | 0.42 | 0.70 | 0.70 | 1.11 | |
| Current Ratio | 0.34 | 0.34 | 0.63 | 0.84 | 0.93 | 1.36 | |
| Return on Equity (ROE) | - | - | -108.57% | -46.00% | -1.82% | -18.22% | |
| Return on Assets (ROA) | -24.15% | -24.15% | -13.77% | -8.87% | 0.69% | -6.14% | |
| Return on Invested Capital (ROIC) | -2732.56% | -253.70% | -41.95% | -20.87% | -1.71% | -14.26% | |
| Return on Capital Employed (ROCE) | 129.00% | 129.00% | -171.00% | -41.50% | 2.40% | -14.00% | |
| Earnings Yield | -156.44% | -156.44% | -135.73% | -50.80% | -1.80% | -14.21% | |
| FCF Yield | -6.24% | -6.24% | -3.43% | -2.52% | -16.33% | -6.72% | |
| Buyback Yield / Dilution | -0.03% | -0.03% | -0.09% | 2.14% | 5.05% | -16.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.